FcGPT: Generative AI to design the antibody region that controls immune response, for safer and more effective therapeutics

• Unité de recherche: INNOSUISSE
• Numéro de projet: 139.749 INNO-LS
• Titre du projet anglais: FcGPT: Generative AI to design the antibody region that controls immune response, for safer and more effective therapeutics

Mots-clé (Anglais)

Life sciences, Biotechnology and processing

Résumé des résultats (Abstract) (Anglais)

Fy Cappa Biologics develops an AI platform to create novel antibody Fc regions, the part of an antibody that determines its lifetime, biological activity, and safety. Unlike conventional approaches, the platform generates entirely new designs, expanding opportunities for next-generation medicines.